| |
IN THE NEWS- Glaxo Settles 20,000 Lawsuits Over Avandia, Lawyer Says
February 1,2012 - Diabetes drugs tied to pancreatic cancer risk
January 31, 2012 - GERD Drugs Raise Hip Fracture Risk
January 31, 2012 - Experts want suicide risk warning on ADHD drug
January 30, 2012 - Several FDA committee members had ties to Bayer; watchdog urges new vote.
January 13, 2012 - J&J Sold Insulin Pumps After Learning of Defects, FDA Says
(HTML)
January 11,2012 - Study: Statins linked with small diabetes risk (HTML)
January 10, 2012 - Pfizer Must Pay $45 Million in Prempro Cases, Court Rules
January 5, 2012 - FDA Orders Safety Evaluation of Vaginal Mesh
(HTML)
January 5, 2012 - Lawsuits over failing artificial hips increasing.
(HTML?_R=1)
December 27, 2011 - Study finds new artificial hips, knees not better than older models.
- Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events (HTM
)
December 21, 2011 - Certain NSAIDS may raise risk of rare birth defects.
- Pennsylvania Supreme Court to review punitive damages ruling Prempro case (HTML)
December 9, 2011 - Stronger Label Urged for Yaz (HTML?_R=1)
December 9, 2011 - FDA advisers: Ortho Evra patch needs clearer label
(COM/ARTICLE/2011/12/09/US-FDA-BIRTHCONTROL-PATCH-IDUSTRE7B827N20111209)
December 21, 2011 - Ablechild to be interviewed by CNN (PHP/ABLECHILD-INTERVIEWED-BY-CNN/)
December 5, 2011 - Study finds Metal-on-Metal Hip Implants no better and more risky than older models. (D7434)
November 30, 2011 - Associated Bank to Pay $13M to Settle Overdraft Suits (HTML)
November 30, 2011 - Stronger Cautions Backed on Bone Drugs for Women
September 12, 2011 - Tumor Necrosis Factor-alpha (TNFá) Blockers: Label Change - Boxed Warning Updated for Risk of Infection from Legionella and Listeria
September 7, 2011
FDA notified healthcare professionals that the Boxed Warning for the entire class of Tumor Necrosis Factor-alpha (TNFá) blockers has been updated to include the risk of infection from two bacterial pathogens, Legionella and Listeria. - Miscarriage risk doubles with use of anti-inflammatory drugs
September 6, 2011
Common anti-inflammatory drugs such as ibuprofen and naproxen may increase the chance of miscarriage if they are taken early in pregnancy, a new study suggests. - Bad batteries in defibrillators tied to cardiac deaths
September 2, 2011
Now common in airports, schools and private homes, automated external defibrillators, or AEDs, are designed to save lives by administering shocks to hearts in cardiac arrest. But a new study finds that nearly a quarter of potentially deadly AED failures are caused by problems with batteries. - FDA May Classify Surgical Mesh Devices for Failing Organs as High Risk
September 1, 2011
Johnson & Johnson, Boston Scientific Corp. (BSX) and other makers of surgical mesh may have to submit added safety data to regulators to keep their products on the market under a Food and Drug Administration staff recommendation. - Group seeks ban on pelvic mesh implants
August 25, 2011
A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks. - Abnormal Heart Rhythms Associated With High Doses of Celexa
August 23, 2011
FDA notified healthcare professionals and patients that the antidepressant Celexa (citalopram hydrobromide) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. - DePuy's handling of hip recall sparks questions
August 22, 2011
Johnson & Johnson, which could face billions of dollars in costs over an artificial hip recall, is taking an unusual approach to managing the crisis -- one that could limit its financial exposure, legal experts say - Hot Coffee - A Documentary Film examining 'tort reform' (COM/WATCH?V=BBKRJXEQNT4&FEATURE=RELATED)
August 17, 2011
A Documentary Film examining 'tort reform' and how special interests are trying to eliminate our Constitutional right to trial by jury." - Potential Male Breast Cancer Risk for Men taking Propecia (PHP)
August 4, 2011 - Diflucan (fluconazole): Drug Safety Communication – Long-term, High-dose Use During Pregnancy May Be Associated With Birth Defects
August 3, 2011
The FDA is informing the public that treatment with chronic, high doses (400-800mg/day) of Diflucan (fluconazole) during the first trimester of pregnancy may be associated with a rare and distinct set of birth defects in infants. - FDA: Surgical placement of mesh to repair pelvic organ prolapse poses risks
July 14, 2011
The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients to greater risk than other surgical options. - Takeda, Glaxo Diabetes Treatments Raise Risk of Eye Disease,
Takeda Pharmaceutical Co.’s Actos, the world’s best-selling diabetes treatment, and GlaxoSmithKline Plc. (GSK)’s Avandia raise the risk of an eye disease that can lead to blindness, a study shows. - In Medicine, New Isn’t Always Improved
June 27, 2011
In a highly unusual move, the Food and Drug Administration last month ordered manufacturers of all metal hips to undertake emergency studies of patients. And lawmakers and others are now calling for a tightening of how the F.D.A. scrutinizes new implants — both before and after they are sold. - Pfizer’s Bid to Appeal $58 Million Prempro Jury Award Denied
June 21, 2011
The U.S. Supreme Court refused to hear a Pfizer Inc. (PFE) unit’s appeal of a $58 million award to three Nevada women who contracted breast cancer after taking the company’s Premarin and Prempro menopause drugs. - 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer
June 9, 2011
FDA notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include new safety information about the increased risk of being diagnosed with a more serious form of prostate cancer (high-grade prostate cancer).
- Pfizer Puts Hormone-Drug Settlement Costs At $772M, May Go Higher
May 12, 2011
Pfizer Inc. (PFE) expects to pay at least $772 million to resolve all of the product-liability litigation surrounding its hormone-replacement therapy drugs, but the ultimate tally could be higher. - Hospitalizations, deaths after needle biopsy tests increasing
May 6, 2011
Shane Greenstein only vaguely recalls being told that a prostate biopsy he had in June was negative for cancer. That’s because within two days of the exam he was in the hospital with a potentially deadly blood infection. - SC seeks possible billions in drug marketing suit
April 26, 2011
It's now up to a Spartanburg County judge to decide how much a Johnson & Johnson subsidiary should pay South Carolina for deceptive marketing of an antipsychotic drug. If the judge agrees with attorneys for the state, it could be in the billions of dollars. - FDA Drug Safety Communication: Severe liver injury associated with the use of Multaq
April 25, 2011
The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplant in patients treated with the heart medication dronedarone (Multaq). - Johnson & Johnson Unit Recalls Epilepsy Drug
April 15, 2011
For consumers who have been losing trust and patience with Johnson & Johnson over its manufacturing and quality control issues, the announcement of a recall on Thursday from a company unit that makes neurology drugs may seem all too familiar. - Medication-Related Injuries on the Rise
April 15, 2011
The number of people treated in hospitals in the United States for problems related to medication errors has surged more than 50 percent in recent years. - Breast Device Recall Made Most Severe
April 15, 2011
The recall of a medical device that left particles of tungsten in women’s breasts has been classified as the most serious type of recall, one involving “situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death,” the Food and Drug Administration said on Wednesday. - Pfizer, Lilly Antidepressants Linked to Narrowed Arteries in Older Men
April 5, 2011
Antidepressants may narrow the arteries of middle-aged men, potentially putting them at risk for heart attacks and stroke, researchers said. - Proton Pump Inhibitor Drugs (PPIs) : Safety Alert from FDA
March 2, 2011
FDA notified healthcare professionals and the public that prescription proton pump inhibitor (PPI) drugs may cause low serum magnesium levels (hypomagnesemia) if taken for prolonged periods of time (in most cases, longer than one year). a) if taken for prolonged periods of time (in most cases, longer than one year). - Toyota recalling 2.17 million vehicles in U.S.
February 24, 2011
Toyota Motor Corp. recalled 2.17 million vehicles in the United States on Thursday to address accelerator pedals that could become entrapped in floor mats or jammed in driver's side carpeting, prompting federal regulators to close its investigation into the embattled automaker. - AstraZeneca Said to Pay $150 Million to Settle About 6,000 Seroquel Suits
February 17, 2010
AstraZeneca Plc agreed to pay $150 million to settle more lawsuits claiming its antipsychotic drug Seroquel causes diabetes, pushing the amount the drugmaker has paid to resolve cases over the medicine to almost $350 million, people familiar with the accords said. - Dozens ask sheriff: Where's our money?
January 14, 2011
Dozens of people who are owed money by the Philadelphia Sheriff's Office have been waiting for months or even years to recover the proceeds from real-estate sales, with no coherent explanations for what's taking so long. - Many Defibrillators Implanted Unnecessarily, Study Says
January 4, 2011
Doctors are implanting high-tech heart devices in thousands of people who probably do not need them, a new study finds. The procedures cost more than $35,000, involve surgery and anesthesia, and may unnecessarily harm some patients. - Pfizer Ordered to Pay $1.5 Million in Prempro Damages
January 3, 2011
Pfizer Inc. must pay $1.5 million in damages to a pharmacist who developed breast cancer after taking one of the company’s menopause drugs, a jury in Puerto Rico ruled. - Pfizer Recalls 19,000 Bottles of Lipitor Over Odor
December 21, 2010
Pfizer Inc., the world’s largest drugmaker, will recall about 19,000 bottles of Lipitor tablets distributed in the U.S. after a customer reported a musty odor from bottles in which the drug was packaged, the company said. - The Implants Loophole
December 17, 2010
A recently recalled artificial hip made by a unit of Johnson & Johnson, designed to last 15 years or more, is failing worldwide at unusually high rates after just a few years. - President Obama Signs Claims Resolution Act (COM/WATCH?V=KLSCH30IC68)
December 9, 2010
Th President signed the Claims Resolution Act, allowing billions to be paid out for decades-old claims from African American farmers and native Americans that were mistreated and swindled by the government. - Obama To Sign Historic Settlement To Black Farmers
December 6, 2010
WASHINGTON– Decades-old claims from African American farmers and native Americans that the government mistreated and swindled them out of billions of dollars can finally be settled starting Wednesday.
- House Approves $4.6 Billion Settlement for Indian, Black Farmers
November 30, 2010
The House of Representatives approved a decades-old settlement worth $4.6 billion Tuesday that resolves two class-action suits filed against the federal government by black farmers and Native Americans. - Pfizer Loses Appeal of $58 Million Prempro Jury Award
Pfizer Inc. doesn’t deserve a new trial in a Nevada case over the company’s menopause drugs and must pay a $57.6 million jury award to three women who alleged the pills caused their cancers, the state’s highest court ruled. - Privacy Groups Fault Online Health Sites for Sharing User Data With Marketers
November 24, 2010
QualityHealth is a popular health Web site with more than 20 million registered users that offers online medical information and e-mail newsletters on a variety of topics, including diabetes, allergies, asthma and arthritis. - Children’s Benadryl, Motrin Tablets Recalled
November 23, 2010
Johnson & Johnson, the maker of health care products, has recalled about four million packages of cherry- and grape-flavored Children’s Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin caplets. - FDA pulls Darvon painkiller due to safety risks
November 19, 2010
The maker of the painkiller Darvon is pulling the drug off the market at the request of public health officials who say the more than 50-year-old pill causes potentially deadly heart rhythms. - Johnson & Johnson accused of hiding risks of antibiotic Levaquin.
Johnson & Johnson knew its antibiotic Levaquin increased the risk of tendon damage and failed to properly warn patients or doctors, a lawyer said today at the start of a trial in Minnesota. - Costly, unsafe dialysis leads to thousands of premature deaths in the U.S.
November 10, 2010
U.S. kidney dialysis patients face one of the highest death rates outside of the third world, even though U.S. taxpayers spend more than any other nation: about $77,000 a year per patient, or more than $20 billion per year altogether, according to an investigation by the nonprofit journalism outfit ProPublica.
- Ex-Glaxo Executive Is Charged in Drug Fraud
November 10, 2010
In a rare move, the Justice Department on Tuesday announced that it had charged a former vice president and top lawyer for the British drug giant GlaxoSmithKline with making false statements and obstructing a federal investigation into illegal marketing of the antidepressant Wellbutrin for weight loss. - FDA Issues Another Serious Infusion Pump Recall
November 4, 2010
The FDA has issued a class I recall -- its strictest -- for Symbiq infusion pumps because device failure may prevent patients from receiving life-saving therapy. - Big Pharma executives facing legal threat
October 31, 2010
Rats that infested a Philadelphia warehouse 40 years ago have found their way into the legal nightmares of the nation's drug companies.
- Glaxo to Pay $750 Million for Sale of Bad Products
October 26, 2010
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines. - Hormone therapy raises breast cancer deaths: study
October 20, 2010
Women who took hormone replacement pills had more advanced breast cancers and were more likely to die from them than women who took a dummy pill, raising new concerns about the commonly prescribed drugs, U.S. researchers said on Tuesday. - 17,000 doctors cash in drug company money, report finds
October 19, 2010
More than 17,000 doctors and other health care providers have taken money from seven major drug companies to talk to other doctors about their products, a joint investigation by news organizations and non-profit groups found. - CareFusion recall classified as most serious type
October 15, 2010
The Food and Drug Administration has classified CareFusion Corp's August recall of 17,000 Alaris medication pumps as a Class I recall, the most serious type, the company said on Friday. - FDA warns of thigh fractures with bone drugs
October 14, 2010
Osteoporosis drugs used by millions of women to prevent bones from breaking may increase the chances for an unusual type of thigh fracture, U.S. health officials warned on Wednesday. - Pfizer depression drug ineffective, may be harmful: study
Pfizer's antidepressant reboxetine is an "ineffective and potentially harmful" drug and published data on it overestimates the benefits and underplays the risks, a study by German researchers said on Wednesday. - Drug Side Effects May Include Lawsuits
October 3, 2010
For decades, antipsychotic drugs were a niche product. Today, they’re the top-selling class of pharmaceuticals in America, generating annual revenue of about $14.6 billion and surpassing sales of even blockbusters like heart-protective statins. - Crooks 'cram' phone bills with bogus charges
September 30, 2010
There are two ways a con artist can get rich: Steal a lot of money from a few people or steal a little money from a lot of people. Crammers work on volume. They bill telephone customers for small unauthorized amounts, sometimes as little as $2 or $3. - Glaxo's Avandia Cover-Up
September 29, 2010
LAST THURSDAY, US and European regulators delivered a major blow to one of the world's largest drug manufacturers, GlaxoSmithKline. The European Medicines Agency suspended sales of the pharma giant's multibillion-dollar diabetes drug, Avandia, which has been linked to heart attacks and other cardiac problems, saying that its "benefits…no longer outweigh its risks." The Food and Drug Administration severely restricted use of the drug to patients for whom there are no other options, stopping short of pulling Avandia off the market. - For-profit colleges under fire over value, accreditation
September 27, 2010
For Chelsi Miller, the wake-up call came when University of Utah officials said her credits wouldn't transfer from her old school. - Novartis Hid Bone Drugs’ Risks, Lawyer Tells Jury
September 23, 2010
Novartis AG officials hid the health risks of the drugmaker’s bone-strengthening medicines Aredia and Zometa, which a woman says destroyed her jaw, a lawyer told a New Jersey jury. - U.S., Europe move to restrict use of diabetes drug Avandia
September 23, 2010
The diabetes drug Avandia will be pulled from the market in Europe and will only be available in the United States under tough new restrictions, regulators said Thursday in an unusual coordinated announcement. - U.S. Seeks to Join Pfizer Whistleblower Lawsuit
September 22, 2010
The U.S. Justice Department is seeking to join a whistleblower lawsuit over Pfizer Inc.’s organ transplant drug Rapamune alleging the medicine was illegally marketed, according to court papers. - FDA Panel Is Split on Ban of Diet Drug Meridia
September 19, 2010
A divided FDA advisory panel voted eight to eight on whether the weight loss drug Meridia should be allowed to stay on the U.S. market. - Forest, Maker of Celexa, to Pay More Than $313 Million to Settle Marketing Case
September 15, 2010
A unit of Forest Laboratories, the maker of the antidepressant Celexa, agreed on Wednesday to pay more than $313 million to settle criminal and civil complaints, including a claim that it had illegally promoted the drug for use in children. - Black farmer rides tractor named Justice in push for settlement funds
September 15, 2010
John Boyd is a man on a mission. Beginning Thursday, the founder and head of the National Black Farmers Association can be seen driving a spluttering tractor called "Justice" around Capitol Hill, pressing political leaders to provide funds to settle a discrimination case involving minority farmers. - Study: Doctors often fail to disclose company payments
September 13, 2010
A study of orthopedic specialists earning $1 million or more from medical device companies found that doctors often fail to disclose lucrative company ties in medical journal articles, researchers reported Monday. - Wyeth paid writers to promote hormone therapy: study
September 7,2010
Drugmaker Wyeth used ghostwriters to play up the benefits and downplay the harm of hormone replacement therapy in articles published in medical journals, U.S. researchers said on Tuesday. - Common bone drugs linked to esophageal cancer risk
September 2, 2010
People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday. - Child’s Ordeal Shows Risks of Psychosis Drugs for Young
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician trying to quell the boy’s severe temper tantrums. - Diet drug Meridia study renews calls for U.S. ban
September 1, 2010
WASHINGTON — A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. - Pfizer Settles Prempro Case on Breast Cancer Before Retrial on Damages
August 30, 2010
Pfizer Inc. agreed to settle an Arkansas woman’s claims that the company’s Prempro menopause drug caused her breast cancer, avoiding a second punitive damages trial in the case, according to a court filing. - Court awards N.C. couple $1.5 million against Hernia Patch Maker
August 30, 2010
PROVIDENCE — A federal jury has awarded a North Carolina couple $1.5 million for injuries the husband suffered after a hernia patch made by the Cranston firm Davol Inc. ruptured in his abdomen. - The FDA cautions about heart risk with Parkinson's drug Stalevo
August 20, 2010
The Food and Drug Administration on Friday cautioned that it is investigating the possibility that the combination Parkinson's drug Stalevo may increase the risk of heart attack, stroke and death in elderly patients who are taking it. - U.S. Inaction Lets Look-Alike Tubes Kill Patients
August 20, 2010
On its front page, the New York Times (8/21, A1, Harris) reported that "hundreds of deaths or serious injuries" have occurred due "to tube mix-ups" in hospitals. To prevent this problem, "experts and standards groups have advocated since 1996 that tubes for different functions be made incompatible." - ABC News Investigates For-Profit Education: Recruiters at the University of Phoenix
August 19, 2010
Ads for online schools are all over the Internet, plastered on billboards in subway cars and on television. The University of Phoenix, with nearly 500,000 students, is the biggest for-profit college. But some former students said they were duped into paying big bucks and going deeply in debt by slick and misleading recruiters. - FDA Recalls Introducer Device Due to Bleeding Risk
August 15, 2010
The FDA issued a class I recall -- its most serious -- of several St. Jude Medical 6 French Engage Introducer devices because its shaft or hub assembly may break and cause potentially fatal bleeding. - Tylenol tied to childhood asthma and allergies
August 13, 2010
A pair of studies suggests that the common painkiller acetaminophen -- better known as Tylenol in the U.S. -- may be fueling a worldwide increase in asthma. - Health-Fraud Whistleblower Cases May Surge Because of Federal Law Overhaul
July 28, 2010
Federal fraud cases begun by private citizens against drugmakers, insurers and hospitals will probably surge past last year’s record numbers, driven by incentives in the new health law. - Will Black Farmers Get their due? (CNN?IREF=ALLSEARCH)
July 23, 2010
Black farmers have been awarded nearly a billion dollars from the government, but when will Congress hand out the money? - U.S. to Ban Drop-Side Cribs in Infant Safety Overhaul
July 14, 2010
The U.S. Consumer Product Safety Commission, citing 153 deaths in the past four years, voted to ban drop-side cribs in the agency’s first across-the-board overhaul of regulations for infant beds in almost three decades. - Diabetes Drug Maker Hid Test Data on Risks, Files Indicate
July 12, 2010
In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. - Hope Fades For 2 Missing Duck Boat Riders; 11 Hurt, 2 Hospitalized
July 8, 2010
Fox 29 has learned the two people missing in Philadelphia's duck boat crash are from Hungary. Also, the sunken boat has been located in the Delaware River but it is in a deep channel that yields no visibility to divers.
- More Tylenol, Motrin, Benadryl recalled by Johnson & Johnson
July 8, 2010
Johnson & Johnson (JNJ) is expanding a recall of over-the-counter drugs including Tylenol and Motrin IB because of a musty or moldy smell. - Whistleblower Lawsuit Claims Orthopedic Surgeons Overbilled Medicare
July 8, 2010
A prominent Chicago hospital and six orthopedic surgeons defrauded the U.S. government's Medicare and Medicaid programs by overbilling for a heavy caseload of surgeries the doctors often didn't attend, according to allegations in a whistleblower lawsuit filed by a surgeon and a former hospital employee. - Tyco Electronics Faces Whistleblower Suit by Manager
July 8, 2010
July 8 (Bloomberg) -- Tyco Electronics Corp. was sued by a former employee who claims he was fired for disclosing fraudulent accounting practices at the maker of electronic connectors. - VA hospital may have infected 1,800 veterans with HIV
July 1, 2010
A Missouri VA hospital is under fire because it may have exposed more than 1,800 veterans to life-threatening diseases such as hepatitis and HIV. - Avastin May Cause Kidney Damage
June 30, 2010
Kidney problems are the second serious condition linked to the cancer drug. Last year it was found that some patients on Avastin were at elevated risk of intestinal perforations. - Heart Risks Seen in Diabetes Medicine
June 28, 2010
Two studies published in influential medical journals and using very different methods found that Avandia, a controversial diabetes medicine made by GlaxoSmithKline, substantially increased patients’ heart risks. - High court rejects drug maker's appeal
June 21, 2010
The Supreme Court is allowing a new trial in the case of a woman who got breast cancer after taking hormone replacement therapy and is seeking punitive damages against Wyeth Pharmaceuticals. - FDA: Pfizer will pull ineffective leukemia drug
June 21, 2010
Federal health regulators said Monday that the drugmaker Pfizer has agreed to pull a leukemia drug off the market after a follow-up study showed it failed to slow the disease. - J.&J. Unit Under Scrutiny Recalls Additional Over-the-Counter Drugs
June 16, 2010
The Johnson & Johnson unit whose recall of liquid children’s Tylenol and other pediatric medicines is under Congressional investigation said on Tuesday evening that it was recalling additional over-the-counter drugs. - Popular blood pressure pills linked to cancer
June 13, 2010
Some of the world's most popular blood pressure pills may slightly increase your risk of getting cancer, but doctors say it's too soon to ditch the drugs, according to new research. - Insurer sues Pfizer for paying kickbacks to docs
June 11, 2010
A Texas health insurance company is suing Pfizer Inc. saying the drug maker deceptively marketed three of its top-selling drugs, illegally encouraging doctors to prescribe them for non-approved uses and paying kickbacks to doctors. - U.S. Lawmakers to Investigate Wyeth Illegal Marketing
June 11, 2010
House lawmakers will investigate Wyeth, the drugmaker purchased last year by Pfizer Inc., after reports the organ transplant drug Rapamune was illegally marketed for unapproved uses. - Chairman Towns Announces Inquiry into Allegations Wyeth Marketed Rapamune to African Americans for Purposes Unapproved by the FDA
June 11, 2010
Chairman Edolphus “Ed” Towns (D-NY) today launched an investigation into Wyeth Pharmaceuticals, Inc. amid reports alleging the company illegally promoted the kidney transplant drug Rapamune for treatments not approved by the Food and Drug Administration (FDA), and specifically targeted African-Americans in its promotional activities. - J&J Misled Pennsylvania on Drug’s Risks, Lawyer Says
June 3, 2010
A Johnson & Johnson unit misled Pennsylvania officials about the health risks of its Risperdal anti-psychotic drug and duped the state into paying $289 million more than it should have for the medicine, a lawyer said. - Tyson Food agrees to pay workers for time putting on protective gear; $500,000 in back wages
June 3, 2010
The Chicago Tribune reported that Tyson Foods Inc. settled a decade-long dispute with the Labor Department by agreeing to pay workers at poultry plants for time they spend putting on and taking off protective clothing.
- Fire Risk Leads to Huge Maytag Dishwasher Recall
June 3, 2010
Maytag Corp. is recalling about 1.7 million dishwashers because of a fire hazard. - F.D.A. Weighs Penalties in Drug Recall
May 27, 2010
The Johnson & Johnson unit that recalled millions of bottles of liquid children’s Tylenol and other pediatric medicines last month may face criminal penalties, product seizures or other sanctions, an official from the Food and Drug Administration said Thursday. - The FDA cites rare risk of liver damage with weight-loss drugs Xenical and Alli
May 26, 2010
The Food and Drug Administration said Wednesday that it is ordering a revision of the labels of the weight-loss drugs Xenical and Alli to warn of the risk of very rare cases of severe liver damage associated with their use. - Johnson & Johnson subsidiaries ordered to pay $81 million for illegally promoting Topamax
May 22, 2010
A Johnson & Johnson unit admitted it illegally marketing its Topamax epilepsy drug for other ailments, fulfilling part of an $81 million settlement reached in April with the government. - J&J to Pay $81 Million, End Federal Cases on Topamax
April 29, 2010
Two units of Johnson & Johnson will pay more than $81 million to resolve criminal and civil claims over illegal promotion of the epilepsy drug Topamax, the U.S. Justice Department said. - For $520 Million, AstraZeneca Will Settle Case Over Marketing of a Drug
April 26, 2010
AstraZeneca has completed a deal to pay $520 million to settle federal investigations into marketing practices for its blockbuster schizophrenia drug, Seroquel. The Justice Department plans a news conference on Wednesday to disclose details of the case, according to two people close to the negotiations who were not authorized to discuss it publicly. - Reid Calls for Fair Legal Settlements of Minority Farmers and Trust Account Holders
April 26, 2010
Nevada Senator Harry Reid released the following statement today calling for fair legal settlements for African American, Native American and Hispanic farmers and Native American trust account holders: - FDA warns Pfizer for lax oversight of drug study
April 21, 2010
Federal regulators say the drugmaker Pfizer has failed to correct problems with its testing procedures that resulted in overdoses of several children during a company trial - Black farmers call on Congress to pay racial bias settlement
April 21, 2010
African-American farmers hoping for government settlement money in a racial bias case met with lawmakers Wednesday and called on Congress to come up with a way to fund the $1 billion deal. - Harrah's Faces OT Suit By Nevada Casino Workers
April 20, 2010
Harrah's Entertainment Inc. is facing a proposed collective and class action that accuses the company of denying employees of its Nevada entertainment empire overtime wages under federal and state labor law. - 3-U.S. objects to Glaxo, Novartis drug promotions
April 16, 2010
GlaxoSmithKline Plc (GSK.L), Novartis AG (NOVN.VX) and Astellas Pharma Inc (4503.T) used misleading promotions for cancer, pain and bladder drugs, U.S. regulators said in letters released on Friday. - Amylin, Lilly’s Byetta May Have Cancer Risk, FDA Says
April 12, 2010
Amylin Pharmaceuticals Inc. and Eli Lilly & Co.’s long-acting Byetta may be tied to increased cancer risk, a top U.S. regulator said, raising concerns that the experimental diabetes drug may need strict warnings. - Pfizer Gives Details on Payments to Doctors
March 31, 2010
Pfizer, the world’s largest drug maker, said Wednesday that it paid about $20 million to 4,500 doctors and other medical professionals for consulting and speaking on its behalf in the last six months of 2009, its first public accounting of payments to the people who decide which drugs to recommend. - EarthLink to Pay $3.7 Million to Settle Suit Over Early Termination Fees
March 20, 2010
Atlanta-based Internet service provider EarthLink has settled a long-running class action suit alleging that it improperly levied early termination fees against its customers - Pfizer unit recalls two possibly mislabeled drugs
March 28, 2010
Pfizer Inc's Greenstone LLC unit said on Saturday that it was voluntarily recalling two drugs in the United States because they may have been labeled incorrectly by a third-party manufacturer. - Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud
March 26, 2010
Pfizer Inc. violated U.S. racketeering law in the marketing of its epilepsy drug Neurontin and should pay $142.1 million in damages, a jury decided - Black farmers look forward to USDA settlement
February 25, 2010
After juggling odd jobs to keep his Mississippi farm going for more than half a century, Harvey White figures help from the federal government is long overdue. - Pfizer Must Pay Woman $3.45 Million in Prempro Case
February 22, 2010
Feb. 22 (Bloomberg) -- Pfizer Inc.’s Wyeth unit must pay $3.45 million to a woman who argued the company’s Prempro menopause medicine helped cause her cancer, a Philadelphia jury ruled today - Government Announces $1.25 Billion Settlement in Black Farmer Litigation
February 18, 2010
- Biogen, Elan’s Drug Linked to 35 Brain-Disease Cases
February 16, 2010
Biogen Idec Inc.’s multiple sclerosis drug Tysabri has been linked to four new cases of a life-threatening brain illness, a spokeswoman said. - WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
February 15, 2010
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. - Lawsuit Claims Pfizer Deceived Doctors Into Prescribing Its Cholesterol Drug Lipitor
February 11, 2010
Jesse Polansky, a former director of outcomes management at Pfizer (PFE) from 2001 until 2003, has re-filed his whistleblower lawsuit regarding the cholesterol drug Lipitor, the best-selling prescription substance in the world and the backbone of the company. - FDA seeks to increase oversight of medical radiation
February 10, 2010
Federal regulators will require manufacturers of high-grade medical imaging machines to include safety controls that prevent patients from receiving excessive radiatin doses. - Popular antidepressant interferes with cancer drug
February 9, 2010
The popular antidepressant drug Paxil may interfere with breast cancer treatments, making patients more likely to relapse and die, researchers in Canada reported on Monday. - Studies Link Rare Ailment to Pain Pumps
January 27, 2010
When the first cases popped up in orthopedic journals, they read like medical mysteries. Surgeons around the country reported that several active young patients had suddenly developed chondrolysis, a relatively rare ailment in which joint cartilage dies, leaving bone to grind on bone. - Radiation safeguards said to lag amid advances in technology.
January 27, 2010
In New Jersey, 36 cancer patients at a veterans hospital in East Orange were overradiated — and 20 more received substandard treatment — by a medical team that lacked experience in using a machine that generated high-powered beams of radiation. The mistakes, which have not been publicly reported, continued for months because the hospital had no system in place to catch the errors. - Lawsuit claims Medtronic promoted device for off-label uses
January 26, 2010
Medtronic pays doctors to promote a medical device for off-label uses, and the InfuseBone Graft is "unreasonably dangerous" because its active ingredient can travel from the implant site to the esophagus or trachea, turning soft tissue into bone, a married couple claims in Los Angeles Superior Court.
- Drugs for depression, anxiety tied to preterm birth
January 21, 2010
Researchers found that among nearly 3,000 women who gave birth in Washington State, those who started taking antidepressants known as selective serotonin reuptake inhibitors (SSRIs) in the second or third trimester had a higher risk of preterm birth. - Group Urges Recall of Drug for Fibromyalgia
January 20, 2010
A consumer advocacy group is asking government regulators to recall a drug they approved last year for a little-understood pain ailment, saying the pill can lead to dangerously high blood pressure - Strollers Recalled in U.S. on Finger Amputation Risk
January 20, 2010
Jan. 20 (Bloomberg) -- Newell Rubbermaid Inc. is recalling 1.5 million strollers after reports of children’s fingertips getting caught in the products’ hinges, resulting in cuts and amputations, the U.S. Consumer Product Safety Commission said. - HRT raises risk of rare type of breast cancer
January 14, 2010
WASHINGTON — Hormone replacement therapy can raise the risk of an uncommon type of breast cancer fourfold after just three years, U.S. researchers reported on Monday.
They found women who took combined estrogen/progestin hormone-replacement therapy for three years or more had four times the usual risk of lobular breast cancer.
Their study, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, is one of dozens trying to paint a clearer picture of what dangers might come from taking HRT to treat menopause symptoms. - Pfizer Must Face Menopause-Drug Award, Court Finds (Update2)
December 31, 2009
A Pfizer Inc. unit must face a $1.5 million damage award over one of its menopause drugs, a Pennsylvania appeals court ruled. - Pfizer Jury Said to Set Prempro Punitive Damages at $8 Million
December 23, 2009
Jurors said in 2007 that a Pfizer Inc. unit should pay more than $8 million in punitive damages to a woman who blamed the company’s menopause drugs for her breast cancer, according to people familiar with the sealed figure. - Bone Drug/Cancer News Highlights Women's Risky Therapy Choices
December 15, 2009 - Menopause: Marketing Fear
December 15, 2009 - Menopause, as Brought to You by
Big Pharma
December 13, 2009
MILLIONS of American women in the 1990s were told they could help their bodies ward off major illness by taking menopausal hormone drugs. Some medical associations said so. Many gynecologists and physicians said so. Respected medical journals said so, too. - CT Brain Perfusion Scans Safety Investigation
December 7, 2009
The FDA has identified at least 50 additional patients who were exposed to excess radiation of up to eight times the expected level during CT perfusion scans. - Risk of Neural Tube Birth Defects following prenatal exposure to Valproate
December 3, 2009
The FDA is reminding health care professionals about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodiumand related products (valproic acid and divalproex sodium) during pregnancy. - FDA Drug Safety Newsletter-Post Market Reviews
December 3, 2009 - Wal-Mart to Pay $40M to Workers in Mass.
December 2, 2009
Wal-Mart has agreed to pay $40 million to 87,500 employees who claimed they refused overtime. . . - The FDA May Tighten Rules on Omniscan, a GE MRI Drug
December 2, 2009 - BIG PHARMA'S CRIME SPREE
December 2, 2009
Rather than having a deterrent effect, the number of Big Pharma high profile criminal settlements is increasing and the settlements are getting bigger. - Batch of H1N1 vaccine pulled after bad reactions
November 20, 2009
More than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they'd noticed a higher-than-usual number of allergic reactions from one batch - New Pain Device Warnings
November 17, 2009
Federal regulators are demanding changes to labels on devices that deliver pain killers directly to joints after surgery, in response to numerous reports of irreversible cartilage damage.
- Report shows Pfizer's hand in Neurontin studies
November 11, 2009
A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research. -
Certain antibiotics may up birth defect risk
November 3, 2009
Some of the antibiotics used to treat urinary tract infections during pregnancy may increase the risk of several birth defects if a woman uses them early in pregnancy, a new study in the Archives of Pediatrics & Adolescent Medicine shows. - Wyeth to Face New Trial on Punitive Damages in Hormone Replacement Case
November 2, 2009 - FDA Questions Role of Payments in Zimmer Study
November 2, 2009
Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. - Study Finds Stroke Risk from Anemia Drug Aranesp
October 30, 2009
A new study raises fresh safety concerns about widely used anemia medicines. - Amylin, Lilly’s Byetta Gets Stronger Safety Warning
October 30, 2009
Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine’s use by patients with severe kidney disease. - Pfizer Unit’s Prempro Punitive Damages Verdict Remains Secret
Pfizer Unit’s Prempro Punitive Damages Verdict Remains Secret - Judge seals damage award against Wyeth
October 27, 2009
A Philadelphia jury yesterday awarded punitive damages to an Illinois woman who said Wyeth's Prempro hormone replacement therapy caused her breast cancer, but the world will have to wait at least another month before anyone knows how much. - Pa. jury returns verdict in Prempro-cancer case
October 26, 2009
A Philadelphia jury returned a sealed punitive-damages verdict Monday against drugmaker Wyeth Pharmaceuticals after finding a link between a woman's breast cancer and the hormone-replacement drug she took. - Pfizer Unit Must Pay Prempro Damages, Jury Concludes
October 23, 2009
A Pfizer Inc. unit concealed the breast-cancer risks of its hormone-replacement therapy drug Prempro and is liable for $3.7 million in damages to an Illinois woman, a Philadelphia jury ruled in the second phase of a trial. - Glaxo must pay $2.5M in Paxil Case
October 13, 2009
GlaxoSmithKline P.L.C. must pay $2.5 million to settle a claim that its antidepressant Paxil caused severe heart defects in a 3-year-old Bensalem boy, a Philadelphia Common Pleas Court jury found today.
- Antidepressants May Be Linked to Birth Problems
Fall, 2009
Taking a popular type of antidepressant during pregnancy may increase the risk for preterm birth, the need for treatment in a neonatal intensive care unit and lower overall health for the baby, according to a new study.
- Concerns over oral contraceptives spur investigations, FDA review.
September 26, 2009
The oral contraceptives Yaz and Yasmin put women at higher risk for blood clots, strokes and other health problems than some other birth control pills do.
- FDA says updated Januvia label to contain information about acute pancreatitis risk. (HTML)
September 26, 2009 - FDA continues to receive reports of progressive multifocal leukoencephalopathy in patients receiving Tysabri
September 17, 2009
- Immunosuppressant Drugs: Required Labeling Changes - stronger warnings about the risk of BK virus-associated nephropathy (HTM )
July 14, 2009 - Pfizer Can't Exclude Witnesses in Neurontin Suits (COM/APPS/NEWS?PID=EMAIL_EN&SID=AURHVTRS4NSY)
May 8, 2009 - Antidepressant Suicide Cases Revived by Supreme Court (COM/APPS/NEWS?PID=NEWSARCHIVE&SID=AKLQDAGAWRE0)
March 9, 2009 - Wyeth, Drugmakers Lose as Top Court Allows Suits (COM/APPS/NEWS?PID=20601087&SID=AJHVUGV0AW4U&REFER=HOME)
March 4, 2009
"The decision means that product-liability cases that had been delayed while judges waited for the Supreme Court decision can now go forward," said Tobi Millrood, who represents women suing over Wyeth’s Premarin and Prempro menopause drugs.
“The decision makes clear that victims injured by these products are entitled to their day in court.”
- Raptiva "Dear Healthcare Professional" Letter (PDF)
- GENENTECH PROVIDES BLACK BOX WARNING FOR PSORIASIS DRUG RAPTIVA (HTML)
October 17, 2008
Updated Raptiva warnings to include risk of of life-threatening infections including bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML). - "Get Out of Jail Free: How the Bush Administration Helps Corporations Escape Accountability" (PDF)
October 15, 2008
Washington—In a stealth effort coordinated at the highest levels of the Bush administration, multiple federal agencies were repeatedly ordered to usurp state law and undermine consumer protections, according to documents obtained through repeated FOIA requests by the American Association for Justice (AAJ). The documents released today detail how helping corporations escape accountability for dangerous products has been the administration’s top priority.
- Levine v Wyeth - Briefs Submitted to the U.S. Supreme Court
Several interested parties have filed "friend of the court" briefs on the issue of preemption currently before the U.S. Supreme Court in Levine v. Wyeth. - MedWatch - Fluoroquinolones: Boxed Warning to be added for risk of tendon rupture and tendinitis.
July 8, 2008 - FDA urging black box warning for epilepsy drugs
July 7, 2008 - Appellate Ruling Favors Drug Firms in Lawsuits
April 9, 2008 - Pfizer, GSK Win Ruling on Lawsuit Limits (COM/APPS/NEWS?PID=20601127&SID=AOZCBAZ2LB0W&REFER=LAW)
April 9, 2008 - FDA Warns of Association between Singulair and Suicide (HTM)
March 27, 2008 - Lawmakers Catch Glaxo Hiding Suicide Risks
February 13, 2008 - FDA Warns of Heparin Contamination (HTM)
February 11, 2008 - Senator Grassley Demands GSK Release Paxil Suicide Reports (HTM)
February 8, 2008 - FDA Issues Alert - Chantix May Cause Suicide (HTML)
February 4, 2008 - FDA Warns of Suicide Caused by Epileptic Drugs Like Neurontin (HTM)
January 31, 2008 - A Pivotal Medical-Device Case
January 3, 2008 - Preemption - Bush Administration Backs Medtronic in Supreme Court
January 1, 2008
According to Attorney Derek Braslow, of the Pennsylvania firm of Pogust & Braslow, "the goal of the Bush Administration's position is to achieve tort reform without obtaining consent from Congress." "The reality of preemption," he says, "allows companies to market unsafe products and avoid being sued when they deceive consumers about safety and effectiveness." - So Far, Victories Are Few as Breast Cancer
Patients Sue Wyeth Over Hormone Therapy
December 17, 2007
Millrood said Wyeth suggested that progestin be added to buffer the endometrium. “Of course, Wyeth was now marketing a known carcinogen (estrogen) to be taken with another promoter of breast tissue growth, progestin, without ever conducting a single study on the effects of breast tissue,” Millrood said. “Wyeth has admitted repeatedly that it never performed any long-term study — on humans or animals — to evaluate the risk of breast cancer in women taking combination estrogen and progestin.” - FDA's Advisor's Conclude "FDA's Flaws Put Lives at Risk"
December 3, 2007 - FDA Issues Early Communication for Chantix
November 21, 2007
The U.S. Food and Drug Administration (FDA), has issued an alert to physicians concerning the anti-smoking medication Chantix and the increased risk of depression, severe mood swings, suicidal ideation (thoughts), and suicidality. Click here to access the FDA's Release. - Pfizer's anti-smoking drug linked to depression -- Chantix
November 21, 2007 - Merck Agrees to Pay $4.85 Billion for Vioxx Claims
November 9, 2007 - Promoting Openness, Full Disclosure, and Accountability
November 9, 2007 - The U.S. Psycho-Pharmaceutical-Industrial Complex As mental illness has become profitable, we are seeing more of it
November 9, 2007 - Report Backs Up Warnings About Drug Avandia
June 27, 2007 - FDA grants priority to test antipsychotic drug for use by teens
June 6, 2007 - 15-Year Follow-Up Schizophrenia Study: No Drugs = Better Chance at Recovery
May 24, 2007 - Open-Source Drug Safety?
May 22, 2007 - WORLD PREMIERE OF "WE'LL TAKE CARE OF YOU" A Documentary Film by Lattanzio Firmian and Alberto Baudo
May 18, 2007 - FDA Issues New Warnings on Antidepressants
May 4, 2007 - The debate over drugs, teen and depression
May 1, 2007 - Patients Diagnosed Schizophrenic and Bipolar To Boost Seroquel Sales
April 11, 2007 - Parties Debate Weight Of FDA Preemption Rule In Zoloft Federal Case
April 3, 2007 - Suicide Warning For Antidepressants Should Be Raised To Include Young Adults, FDA Panel Says
April 3, 2007 - U.S. Drug Safety Laws Must Be Tougher, Families Say (Update1)
March 8, 2007 - Ireland Calls For Halt To Glaxo's Seroxat For Any New Pts
March 7, 2007 - FDA Issues Stronger Warnings for ADHD Stimulants; Warnings Don’t Go Far Enough
November 1, 2006 - Risky Rx: Drug maker's secret strategies ‘Disturbing’ glimpse into how marketing dupes doctors — and patients
August 15, 2006 - FDA red-faced over claims it is suppressing evidence
August 14, 2006 - BMJ Taming Who?
August 14, 2006 - OIG Report: FDA Fails to Monitor Adverse Safety Reports_BMJ--FDA Duplicity Exposed
August 14, 2006 - JAMA says it was misled by researchers
July 12, 2006 - Litigation Inoculation: New FDA policy aims to preempt suits over labels. A U.S. judge here said it was right.
July 9, 2006 - Deadly Newborn Lung Ailment Linked to Late-Pregnancy Depression Drugs
February 8, 2006 - Antidepressants and the risk of birth defects
January 26, 2006 - Antidepressant-suicide link debated
August 29, 2005 - Antidepressant Protest in front of White House
August 29, 2005 - Top-selling drug linked to increased suicide risk
August 22, 2005 - Europe's Medicine Agency Tightens Noose on Antidepressant Prescriptions for Kids
August 21, 2005 - Parents Cautioned About Multiple Psychiatric Medications for Children
August 9, 2005 - August 24 DC Protest Against the FDA- What's Everybody Mad About?
July 24, 2005 - Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft "failure to warn" cases
July 21, 2005 - Antidepressant efficacy may be overblown-experts
July 15, 2005 - 2000 study by Merck showed Vioxx risk
July 3, 2005 - FDA to Boost ADHD Drug Warnings
July 1, 2005 - FDA Moves Toward Harder Line on Suicide Risks
July 1, 2005 - FDA Advisory Suicide Risk for Adults on Antidepressants
July 1, 2005 - FDA: Suicidality in Adults Being Treated with Antidepressant Medications
June 30, 2005 - FDA to Warn on J&J's Concerta Drug
June 29, 2005 - FDA: Concerned With Psychiatric Risks With ADHD Drugs
June 28, 2005 - Hard to swallow Maine shouldn't let drug makers keep safety secrets
June 11, 2005 - Two to two & one/half times greater risk of suicide on antidepressants over placebo (PDF)
June 2005 - Regulator slaps Pfizer on Zoloft ads
May 6, 2005 - Warning on Prozac for children
April 26, 2005 - FDA requests anticonvulsants be reexamined
April 20, 2005 - FDA Antidepressant Medication Guide (PDF)
April 11, 2005 - Drug company rebuked
April 8, 2005 - Antidepressants carry risks
March 4, 2005 - FDA Tones Down Warning on Use Of Antidepressants In Children
March 4, 2005 - Are the SSRIs and Atypical Antidepressants Safe
and Effective for Children and Adolescents?
March 2, 2005 - Warning Didn't Slow Approval of MS Drug
March 2, 2005 - F.D.A. Official Admits 'Lapses' on Vioxx
March 2, 2005 - 10 Voters on Panel Backing Pain Pills Had Industry Ties
February 25, 2005 - NIH Clears Most Researchers In Conflict-of-Interest Probe
February 23, 2005 - Study ties antidepressants to suicide
February 21, 2005 - Drugs Raise Risk of Suicide
February 18, 2005 - FDA Maverick Whips Merck, Pfizer
February 17, 2005 - Whistleblower to Present Pain Drug Data
February 16, 2005 - FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers
February 16, 2005 - FDA Zoloft data
February 7, 2005 - Did Zoloft make him do it?
February 7, 2005 - Papers indicate firm knew possible Prozac suicide risk
January 4, 2005 - FDA Allows Scientist to Publish Data on Vioxx
January 4, 2005 - Choosing their words carefully
December 23, 2004 - Labeling Change Request Letter for Antidepressant Medications
October 28, 2004 - FDA Proposed Medication Guide: About Using Antidepressants in Children or Teenagers
- Suicidality in Children and Adolescents Being
Treated With Antidepressant Medications
October 15, 2004 - FDA Launches a Multi-Pronged Strategy to Strengthen Safeguards for Children Treated With Antidepressant Medications
October 15, 2004 - Congress Hammers FDA Over Handling of SSRIs
October 15, 2004 - FDA of Failing Act on Information About Link Between Antidepressants,
Suicide Risk in Children, Say Lawmakers
September 27, 2004 - US Reviewer Says Pressured in Antidepressant Probe
September 23, 2004 - FDA calls for warning on antidepressants
Drugs linked to increased suicide risk in children
September 15, 2004 - FDA, Psychpharmacologic Drugs Avisory Comm. & Pediatric Advisory Comm. Meeting (PDF)
September 14, 2004 - FDA, Psychpharmacologic Drugs Avisory Comm. & Pediatric Advisory Comm. Meeting (PDF)
September 13, 2004 - Researcher warns against antidepressants for kids
September 13, 2004 - Drugmaker admitted fraud, but sales flourish
August 16, 2004 - FDA Revisits Issue Of Antidepressants for Youths
New Analysis May Pressure Agency to Set Limit on Use Because of Suicide Risk
August 5, 2004 - Lilly Plans Broad Access To Results of Drug Trials
August 3, 2004 - Maker of drug admits hiding its risks
July 24, 2004 - A Medical Journal Quandary: How to Report on Drug Trials
June 21, 2004 - Stronger WARNING for SSRIs and other newer anti-depressants regarding the potential for behavioural and emotional changes, including risk of self-harm. (PDF)
June 2, 2004 - Regulators Want Antidepressants to List Warning
March 23, 2004 - Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications
March 22, 2004 - Company 'held back' data on drug for children
Antidepressant had no effect, leak reveals
February 3, 2004 - FDA, Psychopharmacolgic Drugs Advisory Comm. Meeting (PDF)
February 2, 2004 - Antidepressant Makers Withhold Data on Children
January 29, 2004
|
 |
| |
|
|
|
